nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP2E1—type 2 diabetes mellitus	0.122	0.387	CbGaD
Fluvoxamine—CYP1A2—type 2 diabetes mellitus	0.116	0.369	CbGaD
Fluvoxamine—CYP3A4—type 2 diabetes mellitus	0.077	0.244	CbGaD
Fluvoxamine—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0164	0.0372	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0164	0.0372	CbGbCtD
Fluvoxamine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0164	0.0372	CbGbCtD
Fluvoxamine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0154	0.0349	CbGbCtD
Fluvoxamine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0151	0.0341	CbGbCtD
Fluvoxamine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0146	0.0331	CbGbCtD
Fluvoxamine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0138	0.0312	CbGbCtD
Fluvoxamine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0131	0.0297	CbGbCtD
Fluvoxamine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0131	0.0297	CbGbCtD
Fluvoxamine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0128	0.029	CbGbCtD
Fluvoxamine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0123	0.0279	CbGbCtD
Fluvoxamine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0121	0.0274	CbGbCtD
Fluvoxamine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0117	0.0265	CbGbCtD
Fluvoxamine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0111	0.0253	CbGbCtD
Fluvoxamine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0109	0.0247	CbGbCtD
Fluvoxamine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0109	0.0247	CbGbCtD
Fluvoxamine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0106	0.0239	CbGbCtD
Fluvoxamine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.01	0.0228	CbGbCtD
Fluvoxamine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00995	0.0226	CbGbCtD
Fluvoxamine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00982	0.0223	CbGbCtD
Fluvoxamine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0097	0.022	CbGbCtD
Fluvoxamine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00919	0.0208	CbGbCtD
Fluvoxamine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00887	0.0201	CbGbCtD
Fluvoxamine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00878	0.0199	CbGbCtD
Fluvoxamine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00875	0.0198	CbGbCtD
Fluvoxamine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0083	0.0188	CbGbCtD
Fluvoxamine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00825	0.0187	CbGbCtD
Fluvoxamine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00801	0.0182	CbGbCtD
Fluvoxamine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00791	0.0179	CbGbCtD
Fluvoxamine—CYP3A5—Losartan—type 2 diabetes mellitus	0.0076	0.0172	CbGbCtD
Fluvoxamine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00754	0.0171	CbGbCtD
Fluvoxamine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00726	0.0165	CbGbCtD
Fluvoxamine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00723	0.0164	CbGbCtD
Fluvoxamine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.007	0.0159	CbGbCtD
Fluvoxamine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0067	0.0152	CbGbCtD
Fluvoxamine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00633	0.0143	CbGbCtD
Fluvoxamine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00613	0.0139	CbGbCtD
Fluvoxamine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00566	0.0128	CbGbCtD
Fluvoxamine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00557	0.0126	CbGbCtD
Fluvoxamine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00541	0.0123	CbGbCtD
Fluvoxamine—CYP2C9—Losartan—type 2 diabetes mellitus	0.0051	0.0116	CbGbCtD
Fluvoxamine—ABCB1—Losartan—type 2 diabetes mellitus	0.00495	0.0112	CbGbCtD
Fluvoxamine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0048	0.0109	CbGbCtD
Fluvoxamine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0046	0.0104	CbGbCtD
Fluvoxamine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0046	0.0104	CbGbCtD
Fluvoxamine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00435	0.00986	CbGbCtD
Fluvoxamine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00324	0.00735	CbGbCtD
Fluvoxamine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00296	0.00672	CbGbCtD
Fluvoxamine—SLC6A3—nerve—type 2 diabetes mellitus	0.000484	0.096	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000273	0.0541	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000233	0.0463	CbGeAlD
Fluvoxamine—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000213	0.0423	CbGeAlD
Fluvoxamine—CYP3A7—liver—type 2 diabetes mellitus	0.000178	0.0353	CbGeAlD
Fluvoxamine—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.000172	0.0341	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000152	0.0301	CbGeAlD
Fluvoxamine—SIGMAR1—pancreas—type 2 diabetes mellitus	0.00015	0.0297	CbGeAlD
Fluvoxamine—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000147	0.0292	CbGeAlD
Fluvoxamine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.00014	0.0278	CbGeAlD
Fluvoxamine—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000136	0.027	CbGeAlD
Fluvoxamine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000113	0.0224	CbGeAlD
Fluvoxamine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000112	0.0223	CbGeAlD
Fluvoxamine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000105	0.0209	CbGeAlD
Fluvoxamine—CYP1A1—kidney—type 2 diabetes mellitus	0.000101	0.0201	CbGeAlD
Fluvoxamine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000101	0.02	CbGeAlD
Fluvoxamine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	9.98e-05	0.0198	CbGeAlD
Fluvoxamine—CYP3A5—kidney—type 2 diabetes mellitus	9.92e-05	0.0197	CbGeAlD
Fluvoxamine—CYP2B6—kidney—type 2 diabetes mellitus	9.86e-05	0.0196	CbGeAlD
Fluvoxamine—CYP3A5—pancreas—type 2 diabetes mellitus	9.86e-05	0.0196	CbGeAlD
Fluvoxamine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	9.66e-05	0.0192	CbGeAlD
Fluvoxamine—SIGMAR1—liver—type 2 diabetes mellitus	9.54e-05	0.0189	CbGeAlD
Fluvoxamine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	9.46e-05	0.0188	CbGeAlD
Fluvoxamine—CYP2E1—kidney—type 2 diabetes mellitus	9.26e-05	0.0184	CbGeAlD
Fluvoxamine—CYP1A1—adipose tissue—type 2 diabetes mellitus	9.15e-05	0.0181	CbGeAlD
Fluvoxamine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	9.01e-05	0.0179	CbGeAlD
Fluvoxamine—CYP3A5—adipose tissue—type 2 diabetes mellitus	8.94e-05	0.0177	CbGeAlD
Fluvoxamine—CYP2C19—liver—type 2 diabetes mellitus	7.96e-05	0.0158	CbGeAlD
Fluvoxamine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	7.45e-05	0.0148	CbGeAlD
Fluvoxamine—CYP3A4—kidney—type 2 diabetes mellitus	7.45e-05	0.0148	CbGeAlD
Fluvoxamine—CYP2D6—kidney—type 2 diabetes mellitus	7.33e-05	0.0145	CbGeAlD
Fluvoxamine—CYP1A2—liver—type 2 diabetes mellitus	6.5e-05	0.0129	CbGeAlD
Fluvoxamine—CYP1A1—liver—type 2 diabetes mellitus	6.41e-05	0.0127	CbGeAlD
Fluvoxamine—ABCB1—retina—type 2 diabetes mellitus	6.37e-05	0.0126	CbGeAlD
Fluvoxamine—CYP3A5—liver—type 2 diabetes mellitus	6.27e-05	0.0124	CbGeAlD
Fluvoxamine—CYP2B6—liver—type 2 diabetes mellitus	6.23e-05	0.0124	CbGeAlD
Fluvoxamine—CYP2C9—liver—type 2 diabetes mellitus	6.17e-05	0.0122	CbGeAlD
Fluvoxamine—ABCB1—nephron tubule—type 2 diabetes mellitus	6e-05	0.0119	CbGeAlD
Fluvoxamine—CYP2E1—liver—type 2 diabetes mellitus	5.85e-05	0.0116	CbGeAlD
Fluvoxamine—ABCB1—cardiovascular system—type 2 diabetes mellitus	5.39e-05	0.0107	CbGeAlD
Fluvoxamine—ABCB1—kidney—type 2 diabetes mellitus	5.27e-05	0.0105	CbGeAlD
Fluvoxamine—ABCB1—pancreas—type 2 diabetes mellitus	5.24e-05	0.0104	CbGeAlD
Fluvoxamine—ABCB1—cortex of kidney—type 2 diabetes mellitus	5.13e-05	0.0102	CbGeAlD
Fluvoxamine—ABCB1—adipose tissue—type 2 diabetes mellitus	4.75e-05	0.00942	CbGeAlD
Fluvoxamine—CYP3A4—liver—type 2 diabetes mellitus	4.71e-05	0.00934	CbGeAlD
Fluvoxamine—CYP2D6—liver—type 2 diabetes mellitus	4.63e-05	0.00919	CbGeAlD
Fluvoxamine—Myalgia—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000265	CcSEcCtD
Fluvoxamine—Shock—Metformin—type 2 diabetes mellitus	4.57e-05	0.000265	CcSEcCtD
Fluvoxamine—Insomnia—Orlistat—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Fluvoxamine—Malaise—Losartan—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Fluvoxamine—Anxiety—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Fluvoxamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Fluvoxamine—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.55e-05	0.000264	CcSEcCtD
Fluvoxamine—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.55e-05	0.000264	CcSEcCtD
Fluvoxamine—Vertigo—Losartan—type 2 diabetes mellitus	4.55e-05	0.000263	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.54e-05	0.000263	CcSEcCtD
Fluvoxamine—Somnolence—Valsartan—type 2 diabetes mellitus	4.54e-05	0.000263	CcSEcCtD
Fluvoxamine—Syncope—Losartan—type 2 diabetes mellitus	4.54e-05	0.000263	CcSEcCtD
Fluvoxamine—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.53e-05	0.000262	CcSEcCtD
Fluvoxamine—Leukopenia—Losartan—type 2 diabetes mellitus	4.53e-05	0.000262	CcSEcCtD
Fluvoxamine—Discomfort—Irbesartan—type 2 diabetes mellitus	4.52e-05	0.000262	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.5e-05	0.00026	CcSEcCtD
Fluvoxamine—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.49e-05	0.00026	CcSEcCtD
Fluvoxamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.48e-05	0.000259	CcSEcCtD
Fluvoxamine—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.48e-05	0.000259	CcSEcCtD
Fluvoxamine—Palpitations—Losartan—type 2 diabetes mellitus	4.47e-05	0.000259	CcSEcCtD
Fluvoxamine—Nausea—Glimepiride—type 2 diabetes mellitus	4.46e-05	0.000258	CcSEcCtD
Fluvoxamine—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000258	CcSEcCtD
Fluvoxamine—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.45e-05	0.000257	CcSEcCtD
Fluvoxamine—Nausea—Sitagliptin—type 2 diabetes mellitus	4.44e-05	0.000257	CcSEcCtD
Fluvoxamine—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000257	CcSEcCtD
Fluvoxamine—Asthenia—Glyburide—type 2 diabetes mellitus	4.44e-05	0.000257	CcSEcCtD
Fluvoxamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.44e-05	0.000257	CcSEcCtD
Fluvoxamine—Anorexia—Metformin—type 2 diabetes mellitus	4.43e-05	0.000257	CcSEcCtD
Fluvoxamine—Cough—Losartan—type 2 diabetes mellitus	4.42e-05	0.000256	CcSEcCtD
Fluvoxamine—Urticaria—Gliclazide—type 2 diabetes mellitus	4.42e-05	0.000256	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.41e-05	0.000255	CcSEcCtD
Fluvoxamine—Alopecia—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000255	CcSEcCtD
Fluvoxamine—Fatigue—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000255	CcSEcCtD
Fluvoxamine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.39e-05	0.000254	CcSEcCtD
Fluvoxamine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.39e-05	0.000254	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000254	CcSEcCtD
Fluvoxamine—Oedema—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000254	CcSEcCtD
Fluvoxamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.39e-05	0.000254	CcSEcCtD
Fluvoxamine—Pruritus—Glyburide—type 2 diabetes mellitus	4.38e-05	0.000253	CcSEcCtD
Fluvoxamine—Mental disorder—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000253	CcSEcCtD
Fluvoxamine—Constipation—Valsartan—type 2 diabetes mellitus	4.37e-05	0.000253	CcSEcCtD
Fluvoxamine—Infection—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000252	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.36e-05	0.000252	CcSEcCtD
Fluvoxamine—Fatigue—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000252	CcSEcCtD
Fluvoxamine—Hypotension—Metformin—type 2 diabetes mellitus	4.34e-05	0.000252	CcSEcCtD
Fluvoxamine—Malnutrition—Ramipril—type 2 diabetes mellitus	4.34e-05	0.000251	CcSEcCtD
Fluvoxamine—Shock—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.00025	CcSEcCtD
Fluvoxamine—Pain—Orlistat—type 2 diabetes mellitus	4.31e-05	0.00025	CcSEcCtD
Fluvoxamine—Chest pain—Losartan—type 2 diabetes mellitus	4.31e-05	0.000249	CcSEcCtD
Fluvoxamine—Arthralgia—Losartan—type 2 diabetes mellitus	4.31e-05	0.000249	CcSEcCtD
Fluvoxamine—Myalgia—Losartan—type 2 diabetes mellitus	4.31e-05	0.000249	CcSEcCtD
Fluvoxamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.3e-05	0.000249	CcSEcCtD
Fluvoxamine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000249	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000249	CcSEcCtD
Fluvoxamine—Anxiety—Losartan—type 2 diabetes mellitus	4.29e-05	0.000249	CcSEcCtD
Fluvoxamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000248	CcSEcCtD
Fluvoxamine—Rash—Bromocriptine—type 2 diabetes mellitus	4.27e-05	0.000247	CcSEcCtD
Fluvoxamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.26e-05	0.000247	CcSEcCtD
Fluvoxamine—Tension—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000246	CcSEcCtD
Fluvoxamine—Discomfort—Losartan—type 2 diabetes mellitus	4.26e-05	0.000246	CcSEcCtD
Fluvoxamine—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000246	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000246	CcSEcCtD
Fluvoxamine—Headache—Bromocriptine—type 2 diabetes mellitus	4.24e-05	0.000246	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.24e-05	0.000245	CcSEcCtD
Fluvoxamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.23e-05	0.000245	CcSEcCtD
Fluvoxamine—Nervousness—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000244	CcSEcCtD
Fluvoxamine—Dry mouth—Losartan—type 2 diabetes mellitus	4.21e-05	0.000244	CcSEcCtD
Fluvoxamine—Anorexia—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000242	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.18e-05	0.000242	CcSEcCtD
Fluvoxamine—Paraesthesia—Metformin—type 2 diabetes mellitus	4.18e-05	0.000242	CcSEcCtD
Fluvoxamine—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000241	CcSEcCtD
Fluvoxamine—Confusional state—Losartan—type 2 diabetes mellitus	4.16e-05	0.000241	CcSEcCtD
Fluvoxamine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.16e-05	0.000241	CcSEcCtD
Fluvoxamine—Dyspnoea—Metformin—type 2 diabetes mellitus	4.15e-05	0.00024	CcSEcCtD
Fluvoxamine—Somnolence—Metformin—type 2 diabetes mellitus	4.13e-05	0.000239	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.13e-05	0.000239	CcSEcCtD
Fluvoxamine—Oedema—Losartan—type 2 diabetes mellitus	4.13e-05	0.000239	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.13e-05	0.000239	CcSEcCtD
Fluvoxamine—Infection—Losartan—type 2 diabetes mellitus	4.1e-05	0.000237	CcSEcCtD
Fluvoxamine—Hypotension—Irbesartan—type 2 diabetes mellitus	4.1e-05	0.000237	CcSEcCtD
Fluvoxamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.09e-05	0.000237	CcSEcCtD
Fluvoxamine—Dyspepsia—Metformin—type 2 diabetes mellitus	4.09e-05	0.000237	CcSEcCtD
Fluvoxamine—Tremor—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000235	CcSEcCtD
Fluvoxamine—Shock—Losartan—type 2 diabetes mellitus	4.06e-05	0.000235	CcSEcCtD
Fluvoxamine—Urticaria—Valsartan—type 2 diabetes mellitus	4.06e-05	0.000235	CcSEcCtD
Fluvoxamine—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.05e-05	0.000234	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.04e-05	0.000234	CcSEcCtD
Fluvoxamine—Decreased appetite—Metformin—type 2 diabetes mellitus	4.04e-05	0.000234	CcSEcCtD
Fluvoxamine—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.04e-05	0.000234	CcSEcCtD
Fluvoxamine—Tachycardia—Losartan—type 2 diabetes mellitus	4.03e-05	0.000233	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000233	CcSEcCtD
Fluvoxamine—Nausea—Bromocriptine—type 2 diabetes mellitus	4.02e-05	0.000233	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.01e-05	0.000232	CcSEcCtD
Fluvoxamine—Fatigue—Metformin—type 2 diabetes mellitus	4.01e-05	0.000232	CcSEcCtD
Fluvoxamine—Urticaria—Orlistat—type 2 diabetes mellitus	4.01e-05	0.000232	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4e-05	0.000231	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.99e-05	0.000231	CcSEcCtD
Fluvoxamine—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.99e-05	0.000231	CcSEcCtD
Fluvoxamine—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.99e-05	0.000231	CcSEcCtD
Fluvoxamine—Asthenia—Gliclazide—type 2 diabetes mellitus	3.99e-05	0.000231	CcSEcCtD
Fluvoxamine—Agitation—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000231	CcSEcCtD
Fluvoxamine—Constipation—Metformin—type 2 diabetes mellitus	3.98e-05	0.00023	CcSEcCtD
Fluvoxamine—Angioedema—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000229	CcSEcCtD
Fluvoxamine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.000228	CcSEcCtD
Fluvoxamine—Anorexia—Losartan—type 2 diabetes mellitus	3.94e-05	0.000228	CcSEcCtD
Fluvoxamine—Vomiting—Glyburide—type 2 diabetes mellitus	3.94e-05	0.000228	CcSEcCtD
Fluvoxamine—Pruritus—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.000228	CcSEcCtD
Fluvoxamine—Malaise—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000226	CcSEcCtD
Fluvoxamine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000226	CcSEcCtD
Fluvoxamine—Rash—Glyburide—type 2 diabetes mellitus	3.9e-05	0.000226	CcSEcCtD
Fluvoxamine—Somnolence—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000226	CcSEcCtD
Fluvoxamine—Dermatitis—Glyburide—type 2 diabetes mellitus	3.9e-05	0.000226	CcSEcCtD
Fluvoxamine—Vertigo—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000226	CcSEcCtD
Fluvoxamine—Syncope—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000225	CcSEcCtD
Fluvoxamine—Leukopenia—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000225	CcSEcCtD
Fluvoxamine—Headache—Glyburide—type 2 diabetes mellitus	3.88e-05	0.000224	CcSEcCtD
Fluvoxamine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000224	CcSEcCtD
Fluvoxamine—Hypotension—Losartan—type 2 diabetes mellitus	3.86e-05	0.000223	CcSEcCtD
Fluvoxamine—Palpitations—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000222	CcSEcCtD
Fluvoxamine—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.83e-05	0.000222	CcSEcCtD
Fluvoxamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.000221	CcSEcCtD
Fluvoxamine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000221	CcSEcCtD
Fluvoxamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.8e-05	0.00022	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.8e-05	0.00022	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000219	CcSEcCtD
Fluvoxamine—Cough—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000219	CcSEcCtD
Fluvoxamine—Fatigue—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000219	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.76e-05	0.000218	CcSEcCtD
Fluvoxamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.76e-05	0.000218	CcSEcCtD
Fluvoxamine—Convulsion—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000218	CcSEcCtD
Fluvoxamine—Pain—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.000217	CcSEcCtD
Fluvoxamine—Constipation—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.000217	CcSEcCtD
Fluvoxamine—Insomnia—Losartan—type 2 diabetes mellitus	3.74e-05	0.000216	CcSEcCtD
Fluvoxamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.72e-05	0.000215	CcSEcCtD
Fluvoxamine—Paraesthesia—Losartan—type 2 diabetes mellitus	3.71e-05	0.000215	CcSEcCtD
Fluvoxamine—Urticaria—Metformin—type 2 diabetes mellitus	3.69e-05	0.000214	CcSEcCtD
Fluvoxamine—Chest pain—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000214	CcSEcCtD
Fluvoxamine—Myalgia—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000214	CcSEcCtD
Fluvoxamine—Arthralgia—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000214	CcSEcCtD
Fluvoxamine—Dyspnoea—Losartan—type 2 diabetes mellitus	3.68e-05	0.000213	CcSEcCtD
Fluvoxamine—Anxiety—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000213	CcSEcCtD
Fluvoxamine—Nausea—Glyburide—type 2 diabetes mellitus	3.68e-05	0.000213	CcSEcCtD
Fluvoxamine—Abdominal pain—Metformin—type 2 diabetes mellitus	3.68e-05	0.000213	CcSEcCtD
Fluvoxamine—Dizziness—Gliclazide—type 2 diabetes mellitus	3.68e-05	0.000213	CcSEcCtD
Fluvoxamine—Somnolence—Losartan—type 2 diabetes mellitus	3.67e-05	0.000213	CcSEcCtD
Fluvoxamine—Asthenia—Valsartan—type 2 diabetes mellitus	3.66e-05	0.000212	CcSEcCtD
Fluvoxamine—Discomfort—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000211	CcSEcCtD
Fluvoxamine—Dyspepsia—Losartan—type 2 diabetes mellitus	3.64e-05	0.00021	CcSEcCtD
Fluvoxamine—Asthenia—Orlistat—type 2 diabetes mellitus	3.62e-05	0.00021	CcSEcCtD
Fluvoxamine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.62e-05	0.000209	CcSEcCtD
Fluvoxamine—Pruritus—Valsartan—type 2 diabetes mellitus	3.61e-05	0.000209	CcSEcCtD
Fluvoxamine—Dry mouth—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000209	CcSEcCtD
Fluvoxamine—Decreased appetite—Losartan—type 2 diabetes mellitus	3.59e-05	0.000208	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.59e-05	0.000208	CcSEcCtD
Fluvoxamine—Confusional state—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000207	CcSEcCtD
Fluvoxamine—Pruritus—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000207	CcSEcCtD
Fluvoxamine—Fatigue—Losartan—type 2 diabetes mellitus	3.56e-05	0.000206	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000205	CcSEcCtD
Fluvoxamine—Oedema—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000205	CcSEcCtD
Fluvoxamine—Vomiting—Gliclazide—type 2 diabetes mellitus	3.53e-05	0.000205	CcSEcCtD
Fluvoxamine—Constipation—Losartan—type 2 diabetes mellitus	3.53e-05	0.000204	CcSEcCtD
Fluvoxamine—Pain—Losartan—type 2 diabetes mellitus	3.53e-05	0.000204	CcSEcCtD
Fluvoxamine—Rash—Gliclazide—type 2 diabetes mellitus	3.5e-05	0.000203	CcSEcCtD
Fluvoxamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.5e-05	0.000203	CcSEcCtD
Fluvoxamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.49e-05	0.000202	CcSEcCtD
Fluvoxamine—Urticaria—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000202	CcSEcCtD
Fluvoxamine—Shock—Ramipril—type 2 diabetes mellitus	3.48e-05	0.000202	CcSEcCtD
Fluvoxamine—Headache—Gliclazide—type 2 diabetes mellitus	3.48e-05	0.000202	CcSEcCtD
Fluvoxamine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000201	CcSEcCtD
Fluvoxamine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.47e-05	0.000201	CcSEcCtD
Fluvoxamine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.47e-05	0.000201	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000201	CcSEcCtD
Fluvoxamine—Tachycardia—Ramipril—type 2 diabetes mellitus	3.46e-05	0.0002	CcSEcCtD
Fluvoxamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.45e-05	0.0002	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000198	CcSEcCtD
Fluvoxamine—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.4e-05	0.000197	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.38e-05	0.000195	CcSEcCtD
Fluvoxamine—Dizziness—Valsartan—type 2 diabetes mellitus	3.38e-05	0.000195	CcSEcCtD
Fluvoxamine—Anorexia—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000195	CcSEcCtD
Fluvoxamine—Dizziness—Orlistat—type 2 diabetes mellitus	3.34e-05	0.000193	CcSEcCtD
Fluvoxamine—Asthenia—Metformin—type 2 diabetes mellitus	3.34e-05	0.000193	CcSEcCtD
Fluvoxamine—ABCB1—liver—type 2 diabetes mellitus	3.33e-05	0.00661	CbGeAlD
Fluvoxamine—Hypotension—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000192	CcSEcCtD
Fluvoxamine—Nausea—Gliclazide—type 2 diabetes mellitus	3.3e-05	0.000191	CcSEcCtD
Fluvoxamine—Pruritus—Metformin—type 2 diabetes mellitus	3.29e-05	0.00019	CcSEcCtD
Fluvoxamine—Urticaria—Losartan—type 2 diabetes mellitus	3.28e-05	0.00019	CcSEcCtD
Fluvoxamine—Abdominal pain—Losartan—type 2 diabetes mellitus	3.26e-05	0.000189	CcSEcCtD
Fluvoxamine—Body temperature increased—Losartan—type 2 diabetes mellitus	3.26e-05	0.000189	CcSEcCtD
Fluvoxamine—Vomiting—Valsartan—type 2 diabetes mellitus	3.25e-05	0.000188	CcSEcCtD
Fluvoxamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.23e-05	0.000187	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000187	CcSEcCtD
Fluvoxamine—Rash—Valsartan—type 2 diabetes mellitus	3.22e-05	0.000186	CcSEcCtD
Fluvoxamine—Dermatitis—Valsartan—type 2 diabetes mellitus	3.22e-05	0.000186	CcSEcCtD
Fluvoxamine—Vomiting—Orlistat—type 2 diabetes mellitus	3.21e-05	0.000186	CcSEcCtD
Fluvoxamine—Insomnia—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000185	CcSEcCtD
Fluvoxamine—Headache—Valsartan—type 2 diabetes mellitus	3.2e-05	0.000185	CcSEcCtD
Fluvoxamine—Diarrhoea—Metformin—type 2 diabetes mellitus	3.18e-05	0.000184	CcSEcCtD
Fluvoxamine—Rash—Orlistat—type 2 diabetes mellitus	3.18e-05	0.000184	CcSEcCtD
Fluvoxamine—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000184	CcSEcCtD
Fluvoxamine—Dermatitis—Orlistat—type 2 diabetes mellitus	3.18e-05	0.000184	CcSEcCtD
Fluvoxamine—Headache—Orlistat—type 2 diabetes mellitus	3.16e-05	0.000183	CcSEcCtD
Fluvoxamine—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000183	CcSEcCtD
Fluvoxamine—Asthenia—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000182	CcSEcCtD
Fluvoxamine—Somnolence—Ramipril—type 2 diabetes mellitus	3.15e-05	0.000182	CcSEcCtD
Fluvoxamine—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.12e-05	0.00018	CcSEcCtD
Fluvoxamine—Pruritus—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.00018	CcSEcCtD
Fluvoxamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000178	CcSEcCtD
Fluvoxamine—Dizziness—Metformin—type 2 diabetes mellitus	3.07e-05	0.000178	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000177	CcSEcCtD
Fluvoxamine—Fatigue—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000177	CcSEcCtD
Fluvoxamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.04e-05	0.000176	CcSEcCtD
Fluvoxamine—Nausea—Valsartan—type 2 diabetes mellitus	3.03e-05	0.000176	CcSEcCtD
Fluvoxamine—Constipation—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000175	CcSEcCtD
Fluvoxamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3e-05	0.000174	CcSEcCtD
Fluvoxamine—Nausea—Orlistat—type 2 diabetes mellitus	3e-05	0.000173	CcSEcCtD
Fluvoxamine—Asthenia—Losartan—type 2 diabetes mellitus	2.96e-05	0.000172	CcSEcCtD
Fluvoxamine—Vomiting—Metformin—type 2 diabetes mellitus	2.96e-05	0.000171	CcSEcCtD
Fluvoxamine—Rash—Metformin—type 2 diabetes mellitus	2.93e-05	0.00017	CcSEcCtD
Fluvoxamine—Dermatitis—Metformin—type 2 diabetes mellitus	2.93e-05	0.00017	CcSEcCtD
Fluvoxamine—Pruritus—Losartan—type 2 diabetes mellitus	2.92e-05	0.000169	CcSEcCtD
Fluvoxamine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000169	CcSEcCtD
Fluvoxamine—Headache—Metformin—type 2 diabetes mellitus	2.91e-05	0.000169	CcSEcCtD
Fluvoxamine—Dizziness—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000168	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000168	CcSEcCtD
Fluvoxamine—Diarrhoea—Losartan—type 2 diabetes mellitus	2.83e-05	0.000164	CcSEcCtD
Fluvoxamine—Urticaria—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000163	CcSEcCtD
Fluvoxamine—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.8e-05	0.000162	CcSEcCtD
Fluvoxamine—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.8e-05	0.000162	CcSEcCtD
Fluvoxamine—Vomiting—Irbesartan—type 2 diabetes mellitus	2.79e-05	0.000162	CcSEcCtD
Fluvoxamine—Rash—Irbesartan—type 2 diabetes mellitus	2.77e-05	0.00016	CcSEcCtD
Fluvoxamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.00016	CcSEcCtD
Fluvoxamine—Nausea—Metformin—type 2 diabetes mellitus	2.76e-05	0.00016	CcSEcCtD
Fluvoxamine—Headache—Irbesartan—type 2 diabetes mellitus	2.75e-05	0.000159	CcSEcCtD
Fluvoxamine—Dizziness—Losartan—type 2 diabetes mellitus	2.73e-05	0.000158	CcSEcCtD
Fluvoxamine—Vomiting—Losartan—type 2 diabetes mellitus	2.63e-05	0.000152	CcSEcCtD
Fluvoxamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000151	CcSEcCtD
Fluvoxamine—Nausea—Irbesartan—type 2 diabetes mellitus	2.61e-05	0.000151	CcSEcCtD
Fluvoxamine—Rash—Losartan—type 2 diabetes mellitus	2.6e-05	0.000151	CcSEcCtD
Fluvoxamine—Dermatitis—Losartan—type 2 diabetes mellitus	2.6e-05	0.000151	CcSEcCtD
Fluvoxamine—Headache—Losartan—type 2 diabetes mellitus	2.59e-05	0.00015	CcSEcCtD
Fluvoxamine—Asthenia—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000147	CcSEcCtD
Fluvoxamine—Pruritus—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000145	CcSEcCtD
Fluvoxamine—Nausea—Losartan—type 2 diabetes mellitus	2.45e-05	0.000142	CcSEcCtD
Fluvoxamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.42e-05	0.00014	CcSEcCtD
Fluvoxamine—Dizziness—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000136	CcSEcCtD
Fluvoxamine—Vomiting—Ramipril—type 2 diabetes mellitus	2.25e-05	0.00013	CcSEcCtD
Fluvoxamine—Rash—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000129	CcSEcCtD
Fluvoxamine—Dermatitis—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000129	CcSEcCtD
Fluvoxamine—Headache—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000128	CcSEcCtD
Fluvoxamine—Nausea—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000122	CcSEcCtD
Fluvoxamine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.43e-06	5.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	3.38e-06	5.17e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.37e-06	5.16e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	3.37e-06	5.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.37e-06	5.15e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.36e-06	5.14e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.34e-06	5.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.33e-06	5.09e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	3.32e-06	5.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.32e-06	5.07e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.32e-06	5.07e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.31e-06	5.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.3e-06	5.05e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	3.29e-06	5.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.29e-06	5.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.29e-06	5.03e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	3.28e-06	5.02e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.25e-06	4.97e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.24e-06	4.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.24e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.24e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.24e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.24e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	3.23e-06	4.94e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.2e-06	4.9e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.18e-06	4.86e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	3.18e-06	4.86e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	3.18e-06	4.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.15e-06	4.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.15e-06	4.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.14e-06	4.8e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.14e-06	4.8e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.13e-06	4.79e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.13e-06	4.78e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	3.11e-06	4.76e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.11e-06	4.75e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.11e-06	4.75e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.11e-06	4.75e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	3.1e-06	4.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.09e-06	4.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.08e-06	4.72e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.08e-06	4.72e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.08e-06	4.71e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.07e-06	4.7e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.07e-06	4.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	3.05e-06	4.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.05e-06	4.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.04e-06	4.65e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.03e-06	4.64e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.03e-06	4.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.03e-06	4.64e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.02e-06	4.62e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.98e-06	4.55e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.96e-06	4.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.96e-06	4.53e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	2.96e-06	4.52e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.93e-06	4.48e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.92e-06	4.46e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	2.91e-06	4.45e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	2.91e-06	4.44e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	2.9e-06	4.43e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.89e-06	4.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.88e-06	4.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	2.86e-06	4.38e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.86e-06	4.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.86e-06	4.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.86e-06	4.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.86e-06	4.37e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.86e-06	4.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.84e-06	4.35e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.84e-06	4.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.83e-06	4.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.83e-06	4.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.83e-06	4.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.82e-06	4.31e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.81e-06	4.3e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.81e-06	4.29e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.81e-06	4.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.81e-06	4.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.81e-06	4.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.79e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.79e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.79e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.78e-06	4.25e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.77e-06	4.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.77e-06	4.23e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.76e-06	4.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.76e-06	4.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.73e-06	4.18e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.72e-06	4.17e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.72e-06	4.16e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.7e-06	4.13e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.7e-06	4.13e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.69e-06	4.12e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.69e-06	4.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.69e-06	4.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.68e-06	4.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.68e-06	4.09e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.67e-06	4.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.65e-06	4.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.65e-06	4.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.63e-06	4.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.63e-06	4.01e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.62e-06	4.01e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.62e-06	4.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.6e-06	3.98e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.59e-06	3.96e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.58e-06	3.94e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.55e-06	3.89e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.55e-06	3.89e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.54e-06	3.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.53e-06	3.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	2.52e-06	3.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.52e-06	3.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.5e-06	3.82e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.5e-06	3.82e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.5e-06	3.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.5e-06	3.82e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.49e-06	3.8e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	3.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.47e-06	3.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.46e-06	3.76e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.45e-06	3.75e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.45e-06	3.75e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.44e-06	3.73e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.44e-06	3.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.43e-06	3.72e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.42e-06	3.7e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.42e-06	3.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.42e-06	3.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.42e-06	3.7e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.41e-06	3.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.41e-06	3.68e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.4e-06	3.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.38e-06	3.64e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.38e-06	3.64e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.38e-06	3.64e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.37e-06	3.63e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.36e-06	3.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.35e-06	3.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.35e-06	3.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.34e-06	3.58e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.34e-06	3.58e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.32e-06	3.55e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.32e-06	3.55e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.31e-06	3.54e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.31e-06	3.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-06	3.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-06	3.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.3e-06	3.51e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-06	3.51e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-06	3.51e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.29e-06	3.5e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.29e-06	3.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.28e-06	3.48e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	2.27e-06	3.47e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.26e-06	3.46e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.26e-06	3.46e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.25e-06	3.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.23e-06	3.4e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.21e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.2e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.19e-06	3.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.18e-06	3.33e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	2.17e-06	3.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.17e-06	3.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.17e-06	3.32e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.17e-06	3.31e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.17e-06	3.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.16e-06	3.31e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.16e-06	3.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.16e-06	3.3e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.15e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.15e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.14e-06	3.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.11e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.1e-06	3.21e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.09e-06	3.2e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.07e-06	3.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.07e-06	3.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.03e-06	3.1e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.02e-06	3.08e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	3.04e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.98e-06	3.03e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.98e-06	3.02e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.95e-06	2.98e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.9e-06	2.9e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.89e-06	2.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-06	2.88e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.87e-06	2.86e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.87e-06	2.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.86e-06	2.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.86e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.86e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.85e-06	2.83e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.85e-06	2.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.85e-06	2.82e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.84e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.83e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.81e-06	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.78e-06	2.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.78e-06	2.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.78e-06	2.72e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.73e-06	2.65e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.73e-06	2.65e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.73e-06	2.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.71e-06	2.61e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.7e-06	2.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.69e-06	2.59e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.67e-06	2.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.66e-06	2.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.63e-06	2.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.63e-06	2.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.62e-06	2.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.62e-06	2.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.62e-06	2.48e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.62e-06	2.47e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.61e-06	2.46e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.6e-06	2.44e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.59e-06	2.42e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.58e-06	2.41e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.53e-06	2.34e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.5e-06	2.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.49e-06	2.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	2.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-06	2.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.46e-06	2.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.45e-06	2.21e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.43e-06	2.19e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.43e-06	2.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.41e-06	2.16e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	2.12e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	2.12e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.27e-06	1.94e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.24e-06	1.9e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.22e-06	1.86e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.12e-06	1.71e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.65e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.07e-06	1.63e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.07e-06	1.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	1.62e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	1.61e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	9.98e-07	1.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.77e-07	1.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.17e-07	1.25e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	7.97e-07	1.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.51e-07	1.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.45e-07	1.14e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.36e-07	9.73e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.91e-07	7.51e-06	CbGpPWpGaD
